Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. - Wikidata - awgldk - TriplyDB

Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury.

Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury.

http://www.wikidata.org/entity/Q35083612

about

The myofibroblast: one function, multiple origins Host responses in tissue repair and fibrosis Recent developments in myofibroblast biology: paradigms for connective tissue remodeling Myofibroblasts and lung fibrosis induced by carbon nanotube exposure Chromium genotoxicity: A double-edged sword Modulation of the mevalonate pathway by akt regulates macrophage survival and development of pulmonary fibrosis Targeting the isoprenoid pathway to abrogate progression of pulmonary fibrosis The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis Innovative approaches to the therapy of fibrosis miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis Mast cells and hypoxia drive tissue metaplasia and heterotopic ossification in idiopathic arthrofibrosis after total knee arthroplasty.Therapeutic targeting of SRC kinase in myofibroblast differentiation and pulmonary fibrosis.Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome.Focal adhesion kinase protein regulates Wnt3a gene expression to control cell fate specification in the developing neural plate.IL-13 induces YY1 through the AKT pathway in lung fibroblasts.Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis.Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.Transgenic expression of an altered angiotensin type I AT1 receptor resulting in marked modulation of vascular type I collagen Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation.Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up Mechanisms of pulmonary fibrosis: role of activated myofibroblasts and NADPH oxidase.Organizing pneumonia in mice and men Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis.Trichostatin A attenuates ventilation-augmented epithelial-mesenchymal transition in mice with bleomycin-induced acute lung injury by suppressing the Akt pathway.Emerging drugs for idiopathic pulmonary fibrosis.Dasatinib inhibits TGFβ-induced myofibroblast differentiation through Src-SRF Pathway.Epithelial-mesenchymal interactions in pulmonary fibrosis.Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy Evolving concepts of apoptosis in idiopathic pulmonary fibrosis.New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.Oxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease.Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.Serine/threonine kinase-protein kinase B and extracellular signal-regulated kinase regulate ventilator-induced pulmonary fibrosis after bleomycin-induced acute lung injury: a prospective, controlled animal experiment.The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine.X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis.Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?

P2860

Q24683749-D3BF7764-51CF-47AC-8626-15C5E59666DA Q26852800-3FC3FB2A-3981-4532-9B50-4201688EFD05 Q26863751-5262A226-278F-4613-9185-F06DC6B55524 Q27969008-0C33F0C7-5362-4E20-9E4B-745805EDAB67 Q28383439-4D5DAD53-A27D-4C02-94F2-56CE3D3E6062 Q28385018-9B21B76A-FDDE-414E-9B86-D20235971754 Q28387228-F9B5DE45-B303-4977-BA85-5C5F12F4D82C Q33724231-ACD60FB8-1497-4A3C-AF9B-438BEE7BED78 Q33824140-32FC8C18-4067-48BD-95C7-F7C49C16525E Q34044475-DC55BFBD-869D-4274-AC86-8210B4CF7ECE Q34133639-41A42608-48CD-4A5A-BD19-950DB96F6033 Q34186283-3EDF2FEB-79C0-452F-9766-BBFB52D4B36D Q34407148-3E3AFC67-9B8C-44E8-98A8-CF690DCE2A18 Q35083482-37748787-128B-4AB9-881A-347EF3B73929 Q35182151-7A085583-4681-4404-AD5C-BF476838CCF8 Q35236478-B0546C60-6182-43D3-9292-59C833B9A190 Q35621434-08F1866B-8CEC-4CE9-B842-4F0BC2044121 Q35638689-18DEEC0E-21CF-4244-8523-7FDE96CC5B60 Q35677074-A3EAC282-DBB7-4CF3-8520-C441B29B6D68 Q35918710-4FFCEFD9-2D43-4658-B254-453AACBAA52B Q35983620-2B5786F4-D697-4B71-B3E8-9919171A00B4 Q36012302-4E3727A5-5E5C-4030-81BC-8FBC10E1C7E5 Q36012612-0D2F25AF-0E23-4447-A583-E1D3CC68BAAB Q36047448-50CE7DF0-D59E-43C9-9ADD-95AE1F4785F3 Q36229334-4ABE2F8F-18A3-4064-8DA2-6B2BE25EE7F8 Q36289784-1F7AF0EF-4366-41AB-B2C1-F52E77992D9A Q36302828-8F02D33F-43C4-44E7-A837-400B3E56D2ED Q36373463-05FEBE00-E848-428C-88BD-C332A89BAEF0 Q36427136-39697069-E221-4575-83C7-7804297FC0DD Q36440438-19BA1CDA-2481-4597-91AA-7637D997A05B Q36493966-EEAA61A5-2CB5-4EC0-80D4-C61289367242 Q36749464-D590B349-0F99-4BD7-B060-A5416B214A0A Q36847599-612F6D59-935F-426F-ADBE-DACD8DF76DD5 Q36913772-B64939B3-C9CB-4DAF-A5E1-FD31156865B4 Q36955268-52CFF450-8F25-43C3-AE04-67989568027D Q36970923-70B801E4-2906-4A71-B20B-6C9FDB6B0DFF Q37053170-88EF33DC-BDF3-40E8-929B-6ECEADBC403D Q37056479-319972CF-9014-4814-BC42-D5A53A73E08B Q37056483-6C4468EE-310B-424D-81F7-BBC2CB370562 Q37080510-57EF2266-5395-4CF0-B213-7C0CA8A40C5A

P2860

Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury.

http://www.wikidata.org/entity/Q35083612

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Modulation of prosurvival sign ...... gainst fibrotic tissue injury.

@ast

Modulation of prosurvival sign ...... gainst fibrotic tissue injury.

@en

type

label

Modulation of prosurvival sign ...... gainst fibrotic tissue injury.

@ast

Modulation of prosurvival sign ...... gainst fibrotic tissue injury.

@en

prefLabel

Modulation of prosurvival sign ...... gainst fibrotic tissue injury.

@ast

Modulation of prosurvival sign ...... gainst fibrotic tissue injury.

@en

P1433

Q35083612-F9081B83-7C37-40A1-83A4-D1BF65544CDD

P1476

Q35083612-263D1F62-3A57-466B-A6FA-FC8FB7A4141B

P2093

Q35083612-054FE086-4B16-4E0A-9638-C0D2BFA2EBD4

Q35083612-65408DED-C142-4A59-8BDF-FBD12E946A58

Q35083612-A7955F87-4F4F-4786-9130-F2E920812A3E

Q35083612-B0FBAF3F-D991-4F6E-893D-25EC7356FCCE

Q35083612-B628EC28-3A80-4775-AFF0-810ECD82E935

Q35083612-C1F5EAB2-A3CB-42E9-A6C8-C5A3F0F94C09

Q35083612-DF67C684-BD71-4BCC-978E-CB3284E9758A

P2860

Q35083612-0119030D-D3A2-4F5B-AEFE-F8F31DDFE516

Q35083612-03B84027-AA1F-428F-8C86-B093BDEFFE40

Q35083612-05A73156-C3D5-4F40-82EF-6982DACFD05C

Q35083612-0923A095-654D-4A13-9DA1-DCEF95E91BBF

Q35083612-0EB455B5-3A51-44B7-96D0-A9E09C6E568A

Q35083612-13633C64-063C-4F29-9E68-6F40AE05F5CD

Q35083612-147F81FD-06A0-45B1-988A-E248C6B485FD

Q35083612-1EA71A77-7999-430F-BF8E-D3558F7C2E53

Q35083612-2049948D-7838-4328-A258-469605DF3C9E

Q35083612-222F0ECC-1F90-44DE-A119-B4C6DBE7A6CF

P304

Q35083612-C2B1511A-AEB5-4FDA-96BE-2B5E3172CE2A

P31

Q35083612-BDA64675-8041-47A1-A7D4-5AEEC032C09A

P356

Q35083612-3CBF04C9-7E04-4404-8171-BACA6A54543C

P407

Q35083612-FF8D6600-8509-4AD6-8518-865834AC11B9

P433

Q35083612-2702779D-7FD4-41D7-B108-3AE46FF16803

P478

Q35083612-0975E328-4730-4AC1-929B-3FC337E7043F

P50

Q35083612-D90914C9-BCB6-422E-A2CE-41D559E0FEF5

P577

Q35083612-41032C42-E445-47A2-B7CB-10B7F1382CBA

P5875

Q35083612-6EA7C360-D4F9-456F-A10B-B7FA0AD59F10

P698

Q35083612-A631E107-3AEE-40E4-ABBF-E65A7181558B

P932

Q35083612-8966ABB3-7625-424D-B1A6-CF3D18ED1A5F

P356

S0002-9440(10)62260-2

P1433

The American Journal of Pathology

P1476

Modulation of prosurvival sign ...... against fibrotic tissue injury

@en

P2093

Fernando J Martinez

http://www.w3.org/2001/XMLSchema#string

Galen B Toews

http://www.w3.org/2001/XMLSchema#string

Hengmin Zhang

http://www.w3.org/2001/XMLSchema#string

Jeffrey C Horowitz

http://www.w3.org/2001/XMLSchema#string

Ragini Vittal

http://www.w3.org/2001/XMLSchema#string

Theodore J Standiford

http://www.w3.org/2001/XMLSchema#string

Victor J Thannickal

http://www.w3.org/2001/XMLSchema#string

P2860

The phosphoinositide 3-kinase pathway

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

Myofibroblasts and mechano-regulation of connective tissue remodelling

c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis

Cellular survival: a play in three Akts

Cutaneous wound healing

Points of control in inflammation

The specificities of protein kinase inhibitors: an update

Persistent localization of activated extracellular signal-regulated kinases (ERK1/2) is epithelial cell-specific in an inhalation model of asbestosis.

Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice

P304

367-375

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)62260-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P50

Bethany B Moore

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8050117

http://www.w3.org/2001/XMLSchema#string

P698

15681821

http://www.w3.org/2001/XMLSchema#string

P932

1602319

http://www.w3.org/2001/XMLSchema#string